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Neurotrophic Survival Molecules Minireview
for Motoneurons:
An Embarrassment of Riches
Ronald W. Oppenheim target muscle–derived motoneuron survival factors that
the newest suspect in this mystery, cardiotrophin-1Department of Neurobiology and Anatomy
and the Neuroscience Program (CT-1), must be examined (Pennica et al., 1996). The
considerable current interest in the trophic requirementsBowman Gray School of Medicine
Wake Forest University of motoneurons stems from a need to better understand
normal aspects of motoneuron development and fromWinston-Salem, North Carolina 27157-1010
the hope that this knowledge will foster treatment strate-
gies for motor neuron diseases. An interest in the normal
mechanisms of motoneuron development has a longIn the 18th century French comedy, L’Embarras des
Richesses, the Abbe-D’Allainval noted that “the more history beginning at the turn of this century, whereas
efforts to apply this knowledge to human pathology hasalternatives, the more difficult the choice.” This is a
dilemma now facing neurobiologists who study the tro- really only just begun.
Early Attempts to Understandphic requirements of developing vertebrate motoneu-
rons. A relatively large number of putative trophic mole- Motoneuron-Target Interactions
The experiments of M. L. Shorey, begun in 1906 andcules from different gene families that interact with
distinct receptors have now been shown to promote the published in1909, represent the firstsystematic analysis
of the role of skeletal muscle targets in the developmentsurvival of motoneurons in vitro and in vivo (see Table
1). Furthermore, as expected, some of these are present of spinal motoneurons. Following the removal of the
forelimb bud in the chick embryo at a time prior to pe-in the skeletal muscle targets of somatic motoneurons
(e.g., NT-4, BDNF, GDNF, and IGF), whereas others are ripheral axon outgrowth, Shorey reported that muscle
nerves failed to develop and that there was a reductionnot (e.g., CNTF). Therefore, even if members of the latter
group are eventually shown to satisfy most or all of the in the number of brachial motoneurons several days
later. She concluded that “the defects which appear incriteria for a motoneuron survival factor (see below),
they nonetheless still will not pass muster as classic the nervous system are not due to degeneration, but
to the failure of the neuroblasts to develop” (p. 51).target-derived neurotrophic factors. Accordingly, prov-
ing that these non-target-derived factors are biologically Subsequent investigators, including V. Hamburger and
R. Levi-Montalini (for references, see Oppenheim, 1981),relevant survival molecules for motoneurons is only the
first step in understanding their role in the context of confirmed the massive motoneuron loss following limb
bud removal, but ultimately concluded that the loss was,the normal developing embryo in vivo. However, the
mere fact of their existence has led to a conceptual shift in fact, owing to cellular degeneration, not faulty differ-
entiation. Furthermore, once it was recognized that ain that targets are now generally believed to only be part
of the story of motoneuron survival (Oppenheim, 1991; proportion of vertebrate spinal motoneurons (z50%)
also undergo normal degeneration during developmentKorsching, 1993). Nevertheless, just how these various
other suspected sources of trophic signals act (and in- (Hamburger, 1958, 1975), theeffects of limb bud removal
were reinterpreted as being an exaggeration of this nor-teract) together with target-derived factors is still very
poorly understood(Figure 1). Notwithstanding thepossi- mal programmed cell death (PCD). These and otherearly
studies of neuron–target or central–peripheral interac-bly important role of these other non-target-derived tro-
phic signals for motoneuron development and survival, tions that used the limb removal model provided a
framework that led to the discovery of the prototypicalhowever, targets continue to be a major focus of interest
in this field. And it is in the historically older context of target-derived neurotrophic factor, nerve growth factor
Figure 1. Different Potential Sources of Tro-
phic Signals That May Influence Motoneuron
Survival
For references, see Oppenheim et al. (1993).
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Is CT-1 the Long Sought after Target-DerivedTable 1. A Partial List of Growth Factors and Neurotrophic
Agents That Promote Motoneuron Survival In Vitro or In Vivo Survival Factor for Motoneurons?
The latest addition to this list of putative motoneuronBrain-derived neurotrophic factor (BDNF)
survival factors is CT-1 (Pennica et al., 1996). CT-1, aCardiotrophin-1 (CT-1)
recently discovered protein (Pennica et al., 1995a), is aCholine acetyltransferase development factor (CDF)
Ciliary neurotrophic factor (CNTF) member of the IL-6 family of cytokine growth factors
Fibroblast growth factor-1 (FGF-1) that also includes two previously identified members,
Fibroblast growth factor-2 (FGF-2) CNTF and LIF, that promote motoneuron survival. CT-1
Fibroblast growth factor-5 (FGF-5)
induces hypertrophy and promotes survival of culturedGlial cell-line-derived neurotrophic factor (GDNF)
cardiac myocytes, promotes the in vitro survival of ratInsulin
dopaminergic neurons and chick ciliary neurons (Pen-Insulin-like growth factor-1 (IGF-1)
Insulin-like growth factor-2 (IGF-2) nica et al., 1995b; Sheng et al., 1996), and has now been
Interleukin-6 (IL-6) shown in an elegant series of experiments to be present
Leukemia inhibitor factor (LIF) in skeletal muscle and to promote the survival of cul-
Neurite promoting factor (NPF)
tured embryonic rat motoneurons (Pennica et al., 1996).Neurotrophin-3 (NT-3)
Initially, there was speculation that CT-1 might be aNeurotrophin-4 (NT-4)
new ligand for the CNTF or LIF receptor based on reportsPlatelet-derived growth factor (PDGF)
Protease nexin-1 (PN-1) that targeted deletion of either the a subunit of the CNTF
S-100 receptor or the LIF receptor b subunit (which is common
Transforming growth factor-b (TGF-b) to both receptor complexes) results in a 40% loss of
Vasoactive intestinal peptide (VIP)
spinal and cranial motoneurons at birth (DiChiara et al.,
1995; Li et al., 1995), whereas null mutants for the li-
gands, CNTF or LIF, by contrast, fail to show this early
(NGF; Purves and Sanes, 1987; Hamburger, 1993). Al- motoneuron loss (Masu et al., 1993; DiChiara et al., 1995;
though NGF was shown to be important for the survival Escary et al., 1993). The possibility that CT-1 might be
of sensory and sympathetic neurons, motoneuronswere a novel ligand for the CNTF and LIF receptors would
found to be unresponsive. However, it was suspected explain these seemingly counterintuitive results. The
that another factor (or factors) provided by skeletal mus- facts, however, are a little more complicated than this
cle plays a similar role for developing motoneurons as (Pennica et al., 1996). Whereas CT-1 binds to the LIF-Rb
does target-derived NGF for sensory and sympathetic it does not bind to the CNTF-Ra, indicating the presence
neurons. of a novel cytokine receptor a subunit that is necessary
The Modern Search for Motoneuron to mediate the actions of CT-1.
Survival Factors Because the recent history of this field provides sev-
Although several lines of evidence, including the limb eral examples of false hopes and unfulfilled promises,
bud removal model, provided strong circumstantial evi- it seems reasonable to ask what, if anything, about CT-1
dence for theexistence of a muscle-derivedmotoneuron makes it a more plausible candidate target-derived mo-
survival factor, the search for the specific molecule(s) toneuron trophic agent, compared with some of the
involved was hindered by the lack of an appropriate in other previously highly acclaimed putative factors (e.g.,
vitro assay in which candidate molecules could be BDNF, NT-4, GDNF, and IGF). Before reviewing the evi-
tested on purified populations of motoneurons (Varon et dence for CT-1, however, it is important to describe
al., 1982). Beginning in the 1980s, however, increasingly some general criteria used to identify a molecule as a
sophisticated techniques were established for culturing biologically relevant or necessary target-derived sur-
enriched and completely purified populations of moto- vival factor for developing motoneurons. These include
neurons (for references, see Dohrmann et al., 1986; Ara- the following. First, the factor should be present at the
kawa et al., 1990; Bloch-Gallego et al., 1991). With these right time and place (i.e., in myotubes during motoneu-
new methods, it became possible to demonstrate un- ron PCD). Second, it should either be present in limiting
equivocally that optimal motoneuron survival in vitro amounts or motoneurons should have limited access to
depends on as yet unidentified proteinspresent inskele- it. Third, it should be secreted by target cells and interact
tal muscle extracts. At about the same time, an in vivo with signal-transducing receptors at the nerve terminal.
assay for testing the ability of muscle extracts and puri- Fourth, either the factor or the receptor–ligand complex
fied proteins to prevent normal PCD of motoneurons in should be internalized and retrogradely transported and
the chick embryo was developed (Oppenheim et al., should activate a signal transduction pathway that re-
1988, 1993). Because motoneurons continue to be de- sults in motoneuron survival. Fifth, the survival of homo-
pendent on target-derived signals for a short time follow- geneous cultures of motoneurons should be promoted
ing the cessation of normal PCD, a third assay uses by physiological amounts of the factor. Sixth, in vivo
trophic factors in an attempt to rescue motoneurons treatment should rescue motoneurons from normal
from axotomy-induced cell death during this period (for PCD. Last, experimental reductions of endogenous lev-
references, see Li et al., 1994). Collectively, these assays els of the factor should result in the increased death of
provided a powerful means for assessing the biological only those specific neurons thought to require the factor
relevance of putative survival-promoting proteins for for their survival (e.g., motoneurons). For most of the
motoneurons and their use has led to the identification factors listed in Table 1, only one or two, or at best a
of a relatively large number of candidate molecules, few, of these criteria have so far been satisfied, and
CT-1 is no exception. In its favor, CT-1 is expressed atincluding several target-derived factors (Table 1).
Minireview
197
Bloch-Gallego, E., Huchet, M., El M’Hamdi, H., Xie, F.-K., Tanaka,high levels in mouse embryo limb bud during the period
H., and Henderson, C.E. (1991). Development 111, 221–232.of programmed motoneuron death; it is secreted from
DiChiara, T.M., Vejsada, R., Poueymirou, W.T., Acheson, A., Suri,cultured myotubes; approximately 40% of motoneurons
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death; and CT-1 appears to act via a specific novel
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cytokine receptor a subunit. Although this is a very Nature 363, 361–364.
promising beginning, before one’s hopes are raised too Hamburger, V. (1958). J. Anat. 102, 365–410.
high, it is important to remember that other factors (e.g., Hamburger, V. (1975). J. Comp. Neurol. 160, 535–546.
BDNF and NT-4) were also previously shown to satisfy
Hamburger, V. (1993). J. Neurobiol. 24, 893–897.
these as well as additional criteria. Yet, gene knockout
Korsching, S. (1993). J. Neurosci. 13, 2739–2748.
studies failed to substantiate these factors or their re-
Li, L., Oppenheim, R.W., Lei, M., and Houenou, L.J. (1994). J. Neuro-
ceptor, TrkB, as being essential for motoneuron survival biol. 25, 759–766.
(for references, see DiChiara et al., 1995). Accordingly,
Li, M., Sentner, M., and Smith, A. (1995). Nature 378, 724–727.
one has to conclude that the jury is also still out regard-
Masu, Y., Wolf, E., Holtmann, B., Sendtner, M., Brenn, G., and
ing the role of CT-1 as a motoneuron survival factor. A Thoenen, H. (1993). Nature 365, 27–32.
significant loss of motoneurons following targeted dele- Oppenheim, R.W. (1981). In Studies in Developmental Neurobiology:
tion of the CT-1 gene would greatly strengthen its candi- Essays in Honor of Viktor Hamburger, W.M. Cowan, ed. (New York:
dacy as a motoneuron survival factor. However, it will Oxford), pp. 74–133.
still be necessary todemonstrate that such a loss occurs Oppenheim, R.W. (1991). Annu. Rev. Neurosci. 14, 453–501.
by increased normal PCDrather than owing to effects on Oppenheim, R.W., Haverkamp, L.J., Prevette, D., McManaman, J.L.,
proliferation, migration, or differentiation. Additionally, and Appel, S.H. (1988). Science 240, 919–922.
further studies would need to be done to show that Oppenheim, R.W., Prevette, D., Haverkamp, L.J., Houenou, L., Qin-
Wei, Y., and McManaman, J.L. (1993). J. Neurobiol. 24, 1065–1079.target-derived CT-1 is the route by which CT-1 is opera-
tive. Until these and other aspects of the biology of CT-1 Pennica, D., King, K.L., Shaw, K.J., Luis, E., Rullmas, J., Luoh, S.M.,
Darbonne, W.C., Knutzon, D.S., Yen, R., Chien, K.R., Baker, J.B.,are known, its present status as a bona fide muscle-
and Wood, W.J. (1995a). Proc. Natl. Acad. Sci. USA 92, 1142–1146.derived motoneuron trophic factor rests more on future
Pennica, D., Shaw, K.J., Swanson, T.A., Moore, M.W., Shelton, D.L.,promise than on an existing body of compelling evi-
Zioncheck, K.A., Rosenthal, A., Taga, T., Paoni, N.F., and Wood,dence.
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Why Are There So Many Factors That
Pennica, D., Arce, V., Swanson, T.A., Vejsada, R., Pollock, R.A.,Promote Motoneuron Survival? Armanini, M., Dudley, K., Phillips, H.S., Rosenthal, A., Kato, A.C.,
One obvious, albeit trivial, answer to this question is and Henderson, C.E. (1996). Neuron 17, 63–74.
that the action of many of the factors in Table 1 reflect Purves, D., and Sanes, J.R. (1987). Trends Neurosci. 10, 231–235.
pharmacological rather than physiological effects. Other Sheng, Z., Pennica, D., Wood, W.I., and Chien, K.R. (1996). Develop-
more interesting possibilities include the following: all or ment 122, 419–428.
most motoneurons require multiple factors from diverse Shorey, M.L. (1909). J. Exp. Zool. 7, 25–64.
sources for optimal survival (Figure 1); subpopulations Varon, S., Manthorpe, M., and Lango, F.M. (1982). In Human Motor
of motoneurons, based on their function or connectivity, Neuron Diseases, L.P. Rowland, ed. (New York: Raven Press), pp.
require different factors for survival; and motoneurons 453–472.
require distinct factors at different stages of develop-
ment. At present, the available evidence does not ap-
pear to strongly favor any one of these alternatives over
the others, and it remains possible that they are all cor-
rect. (It is nonetheless intriguing that no single putative
motoneuron survival factor [including CT-1] has been
shown to maintain more than 40%–50% of motoneurons
either in vitro or in vivo [for references, see Pennica
et al., 1996; Oppenheim et al., 1993].) Perhaps by this
“embarrassment of riches,” the embryo is trying to tell
us something, but what? The hope, of course, is that
future studies will reduce our ignorance on these mat-
ters and, in doing so, not only provide some final an-
swers regarding the normal biology of motoneuron sur-
vival, but also suggest rational strategies as to how
one might begin to use this information to treat human
pathologies that involve the loss of motoneurons.
Dedicated to Viktor Hamburger on the occasion of his 96th birthday.
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